FRI0017 How Age, Gender and Body Mass Index Affect the Erythrocyte Sedimentation Rate and the C-Reactive Protein in Early Rheumatoid Arthritis

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 387.1-387
Author(s):  
L. Siemons ◽  
P.M. ten Klooster ◽  
H.E. Vonkeman ◽  
P.L. van Riel ◽  
C.A. Glas ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Body Mass Index ◽  
Erythrocyte Sedimentation Rate ◽  
Body Mass ◽  
Early Rheumatoid Arthritis ◽  
Sedimentation Rate ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Erythrocyte Sedimentation

scholarly journals Association of erythrocyte sedimentation rate and C-reactive protein and clinical findings with HLA-DQ8 allele in Rheumatoid Arthritis patients

2019 ◽  
Vol 8 (1) ◽  
pp. e0108 ◽  
Author(s):  
Karim Mowla ◽  
Najmeh Ahmadzadeh Goli ◽  
Reza Kazemi Nezhad ◽  
Zeinab Deris Zayeri ◽  
Mehrdad Dargahi Mal-Amir ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Erythrocyte Sedimentation Rate ◽  
Sedimentation Rate ◽  
Clinical Findings ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Erythrocyte Sedimentation

scholarly journals The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis

2019 ◽  
Vol 91 (5) ◽  
pp. 26-33
Author(s):  
A S Avdeeva ◽  
M V Cherkasova ◽  
D A Kusevich ◽  
V V Rybakova ◽  
A S Artyuhov ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Total Dose ◽  
Erythrocyte Sedimentation Rate ◽  
Sedimentation Rate ◽  
Disease Duration ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Erythrocyte Sedimentation ◽  
Laboratory Biomarkers

Aim: to evaluate the role of laboratory biomarkers in monitoring effectiveness of rituximab (RTM) biosimilar therapy in a total dose of 1200 mg. Materials and methods. 20 patients (pts) with rheumatoid arthritis (RA) (18 woman, mean age 61.5(54-66.5) years, mean disease duration 39.5(20-84) months, mean DAS28 5.6(4.9-6.8)) received two intravenous RTM biosimilar infusions (600 mg №2) in combination with DMARDs and glucocorticoids. Laboratory biomarkers were assessed at baseline and weeks 12 and 24 after the first infusion of RTX. Results. RTM biosimilar induced decreases in DAS28, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) at week 12 and 24, p

Sign in / Sign up

Export Citation Format

Share Document